FDA Drug Application (021142) for OLUX by DELCOR ASSET CORP

Back to FDA Applications sponsored by DELCOR ASSET CORP

Application Number021142
Product Number001
FormAEROSOL, FOAM;TOPICAL
Dosage0.05%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB1 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameOLUX
Active IngredientCLOBETASOL PROPIONATE



Back to FDA Applications sponsored by DELCOR ASSET CORP

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.